- Conditions
- Myelomeningocele
- Interventions
- Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix, Untreated contemporaneous cohort
- Biological · Other
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 19 Weeks to 25 Weeks
- Enrollment
- 55 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- Sacramento, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–7
of 7
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Intermittent Claudication, Peripheral Artery Disease
- Interventions
- PLX-PAD Low dose, PLX-PAD high doses, Double Placebo, high dose +Placebo
- Biological
- Lead sponsor
- Pluristem Ltd.
- Industry
- Eligibility
- 45 Years to 85 Years
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2019
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • Clearwater, Florida • Gainesville, Florida + 12 more
- Conditions
- Peripheral Artery Disease, Peripheral Vascular Disease, Critical Limb Ischemia
- Interventions
- PLX-PAD
- Biological
- Lead sponsor
- Pluristem Ltd.
- Industry
- Eligibility
- 40 Years to 81 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 2
- States / cities
- Birmingham, Alabama • Durham, North Carolina
- Conditions
- Critical Limb Ischemia (CLI)
- Interventions
- PLX-PAD, Placebo
- Biological
- Lead sponsor
- Pluristem Ltd.
- Industry
- Eligibility
- 45 Years to 99 Years
- Enrollment
- 213 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 14
- States / cities
- Irvine, California • Los Angeles, California • Sacramento, California + 9 more
- Conditions
- COVID, ARDS
- Interventions
- PLX-PAD, Placebo
- Biological
- Lead sponsor
- Pluristem Ltd.
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 66 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 13
- States / cities
- Irvine, California • Los Angeles, California • Sacramento, California + 8 more
- Conditions
- Critical Limb Ischemia (CLI)
- Interventions
- PLX-PAD
- Biological
- Lead sponsor
- Pluristem Ltd.
- Industry
- Eligibility
- 45 Years to 99 Years
- U.S. locations
- 2
- States / cities
- Clifton, New Jersey • Teaneck, New Jersey
- Conditions
- Hip Fracture
- Interventions
- PLX-PAD, Placebo
- Drug
- Lead sponsor
- Pluristem Ltd.
- Industry
- Eligibility
- 0 Years to 90 Years
- Enrollment
- 240 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 3
- States / cities
- Sacramento, California • Denver, Colorado • Indiana, Pennsylvania